Publications

What we publish
Unveiling Our Latest findings
  1. Zangene, E., et al. (2025). Missing Values Are Valuable: Shifting Focus from Amount to Form of Missing Data. bioRxiv 2025.08.22.670516; doi:
  2. Gholizadeh, E., et al. (2025). Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations. bioRxiv, 2024.11.08.618644.
  3. Zangene, E., et al. (2023). DORSSAA: Drug-target interactOmics Resource based on Stability/Solubility Alteration Assay. bioRxiv, 2023.12.29.573639. 
Selected publications
  1. Gholizadeh, E., et al. 2025. , Biomedicine & Pharmacotherapy, Volume 192, 2025, 118647.
  2. Nickchi, P., et al. 2025. . Proteomics, e202400238.
  3. Mirzaie, M., et al. 2024. Oncogenesis 13(1):11.
  4. Jafari, M., et al. 2022. . Nature Communications 13 (1): 2128.
  5. Jafari, M., et al. 2021. . Genome Biology 22 (1): 71.
  6. Gholizadeh, E., et al. 2021. . Molecular Pharmacology 99 (5): 308–18.
  7. Barneh, F., et al. 2019. Briefings in Bioinformatics 20 (2): 717–31.
  8. Wang, Z., et al. 2016.. Nature Communications 7 (1): 12846.